Analysed CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) News Sources
Cullinan Therapeutics flags 2026 as “defining year” at Leerink, tees up key CLN-978/CLN-049 data
14-03-2026
marketbeat.com
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
10-03-2026
yahoo.com
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
10-03-2026
yahoo.com
Cullinan Therapeutics Maps 2026 Data Catalysts for Autoimmune CLN-978, AML CLN-049 at TD Cowen Conference
08-03-2026
marketbeat.com
Cullinan Therapeutics Touts 2026 “Defining Year” as T-Cell Engager, Zipalertinib Catalysts Near
20-02-2026
marketbeat.com
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
19-02-2026
yahoo.com
What is the current price of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The current price of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is $14.22.
CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) absolute price change since previous trading day?
The absolute price change of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) since the previous trading day is $-0.3.
CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) percentage price change since previous trading day?
The percentage price change of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) since the previous trading day is -2.0661%.
What is the most recent average sentiment score for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The most recent average sentiment score for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The most recent sentiment for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is .
SEC-8K** Filing Available For CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.